Spin-off company of NCSR Demokritos, with expertise in micro-nanotechnology and surface engineering, preparing high-end consumables for health, food safety, agricultural and environmental applications.

Nanoplasmas owns a patented technology for the modification of surfaces which has been incorporated into microfluidic devices creating lab-on-chip diagnostics. The company has developed a novel bacteria capture lab-on-chip kit for the detection of Legionella pheumophila bacteria in water and a kit for the detection of Covid-19 in human samples and on solid surfaces. Nanoplasmas has several other products in the pipeline based on its innovative plasma nanotexturing technology.